Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-11-07
1977-11-08
Schafer, Richard E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23293A, 23305F, 423 93, 423142, 2523011S, A61K 4300, A61K 2900
Patent
active
040576167
ABSTRACT:
Metal hydroxides such as Fe(OH).sub.2, Fe(OH).sub.3 and Sn(OH).sub.2 are prepared in the form of spherical particles of uniform and controlled size suitable for tagging with a radioactive element such as technetium-99m. Aqueous suspensions of such tagged particles are useful in scintigraphy as lung scanning agents.
REFERENCES:
patent: 3493514 (1970-02-01), Ashby
patent: 3634558 (1972-01-01), Stober
patent: 3937668 (1976-02-01), Zolle
Webber et al., "Demonstration of Thrombophlebitis and Endothelial Damage by Scintiscanning," in Radiology, 100: 93-97, 1971.
Zolle et al., "Preparation of Metabolizable Radioactive Human Serum Albumin Microspheres for Studies of the Circulation," Int. J. App. Radiat. & Iso. 21: 155-167 (1970).
Singh, et al., "Te-Iron Hydroxide Aggregates: A Radiopharmaceutical for Lung Scanning," J. Nuc. Med. 25(4): 283-286, 1971.
Mallinckrodt Inc.
Schafer Richard E.
LandOfFree
Metal hydroxide scintigraphic agents and method of preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metal hydroxide scintigraphic agents and method of preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metal hydroxide scintigraphic agents and method of preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-229597